Tandur Vijayamahantesh K, Inamdar Mohammed Naseeruddin, Orfali Raha, Asdaq Syed Mohammed Basheeruddin, Rabbani Syed Imam
Department of Pharmacology, Al-Ameen College of Pharmacy, Bangalore, India.
Department of Pharmacognosy, College of Pharmacy, King Saud University, PO Box 2457, Riyadh 11451, Saudi Arabia.
Evid Based Complement Alternat Med. 2022 Jun 26;2022:4163008. doi: 10.1155/2022/4163008. eCollection 2022.
Constipation is a common functional gastrointestinal disorder. Medicines derived from nature are routinely used to treat it. The present study evaluates the gut stimulatory activity of (processed powder of ) using and models for gut stimulatory activity.
tests were conducted on isolated rat colon, guinea pig ileum, and rabbit jejunum, while study was performed using mice intestinal transit time. (. ) was tested at doses 0.2-200 mg/mL ( study) and 86.6 mg/kg ( study). studies were done in the presence and absence of atropine sulphate (1 ng/ml). The results were statistically analyzed, and < 0.05 was considered to indicate the significance.
. exhibited dose-dependent increase in the smooth muscle contraction of isolated gut tissues. Presence of atropine minimized the contractile responses and shifted the dose-response curves towards the right-hand side. The intestinal transit time in mice was observed to be increased significantly ( < 0.01) in . -treated animals, when compared with normal animals.
A mild smooth muscle contraction induced by . suggests that it can stimulate intestinal bowel movement without causing spasms. The diminished responses in the presence of atropine indicated that the gut stimulatory activity could be mediated partially through parasympathetic innervations. More studies are needed to determine the precise mechanism of action including the specific active ingredient responsible for the gut stimulatory activity.
便秘是一种常见的功能性胃肠疾病。天然药物常用于治疗便秘。本研究使用肠道刺激活性的离体和整体动物模型评估(某药物)(某药物的炮制粉末)的肠道刺激活性。
在离体大鼠结肠、豚鼠回肠和兔空肠上进行试验,而在小鼠肠道转运时间实验中进行整体动物研究。(某药物)在0.2 - 200mg/mL剂量下进行离体实验,在86.6mg/kg剂量下进行整体动物实验。实验在存在和不存在硫酸阿托品(1ng/ml)的情况下进行。对结果进行统计学分析,P < 0.05被认为具有显著性。
某药物在离体肠道组织的平滑肌收缩中呈现剂量依赖性增加。阿托品的存在使收缩反应最小化,并使剂量 - 反应曲线向右移动。与正常动物相比,在某药物处理的动物中观察到小鼠肠道转运时间显著增加(P < 0.01)。
某药物诱导的轻度平滑肌收缩表明它可以刺激肠道蠕动而不引起痉挛。阿托品存在时反应减弱表明肠道刺激活性可能部分通过副交感神经支配介导。需要更多研究来确定其确切作用机制,包括负责肠道刺激活性的具体活性成分。